August 22, 2019
September events! A Big Data webinar with Dr. Scott Burger, and a talk at CAR-TCR Summit
September marks the start of the autumn conference season in cell and gene therapy, and this fall I’m looking forward to conversations that show how much the field of personalized therapeutics is growing.
In a few weeks, I’ll be giving two presentations focused on topics for a maturing industry looking to scale and evolve. One will be a webinar, co-presented with Dr. Scott Burger, to discuss the role of big data in cell therapy. A separate conference presentation will discuss best practices for making the complex world of cell therapy as easy as possible for hospitals and clinics.
Webinar – Big Data Strategies for Cell Therapy Manufacturing
September 17, 2019
10:00 am EST
I’ll be conducting a webinar with renowned cell therapy scientific leader Dr. Scott Burger. We’ll be focusing on how the quest to retrieve, analyze, and leverage data has become the new gold rush in life sciences. This presentation will discuss the role of big data in cell therapy process development, real time analytics, and commercial scale manufacturing.
Presenters: Scott R. Burger, MD, Principal of Advanced Cell & Gene Therapy, LLC; Heidi Hagen, Chief Strategy Officer and Co-founder, Vineti
Here are the details — I hope you’ll join us.
CAR-TCR Summit Presentation – When the Patient is the Product: Seven Steps for Success
September 11, 2019
3:30 pm EST
The conference has added a Clinical Management track this year, and I’m looking forward to giving the a presentation on best practices for clinical sites including covering topics such as:
- The number and range of clinical sites providing cell therapy is expanding rapidly world-wide
- Amid rapid scale and increasing variability, a set of proven guidelines can help keep cell therapy working smoothly in the clinic
- This presentation will cover seven essential steps that support clinical sites serving cell therapy patients
At Vineti, our software platform helps our partners manage complex cell and gene therapy workflows every day. I’m really looking forward to sharing and learning with the rest of the industry this fall. Please contact us if you’d like to learn more about either presentation.
Heidi Hagen is the Chief Strategy Officer and a Co-founder of Vineti. Over the course of her career, she has overseen the operations and delivery for more than 100,000 doses of cell therapy. If you’d like to learn more about how Vineti’s software platform supports cell therapies as they scale, please contact us to schedule a demo.